SNDX

8.7204.49%
LJ

Luke J. Albrecht

General Counsel & Corporate Secretary

Mr. Luke J. Albrecht is General Counsel at Syndax Pharmaceuticals, Inc. since August 2016 and Secretary since September 2016 and served as its Senior Vice President since February 2020. He was Vice President of Syndax Pharmaceuticals, Inc. since August 2016. Mr. Albrecht served as Vice President, General Counsel and Secretary, Chief Compliance Officer at Boston Heart Diagnostics Corporation from March 2013 to May 16, 2016. Mr. Albrecht's overall responsible for managing Boston Heart's legal affairs and corporate governance activities. Prior to joining Boston Heart, he served as the first in-house counsel for Advanced BioHealing, Inc. He was a senior attorney at Cooley Godward Kronish LLP as well as McDermott Will & Emery LLP, where his practice focused principally in the life sciences and technology industries advising public and private companies, entrepreneurs, investors and board members. He practiced corporate and transactional law at the international law firms McDermott Will & Emery LLP from August 2004 to July 2007 and Cooley LLP from July 2007 to August 2009. At both Cooley and McDermott, he advised on matters ranging from mergers and acquisitions, venture capital financings, commercial contracts, public company reporting, public offerings, securities law compliance, board and duties and other general corporate matters. Mr. Albrecht holds a Bachelor of Arts degree from the University of New Hampshire and a Juris Doctor degree magna cum laude from Suffolk University Law School.

Positions